REGISTERED NUMBER: 12691969 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

B & T PRESCRIPTIONS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

T O Amesimeku

B Tuffour

REGISTERED OFFICE:

Thames House, 2nd Floor

3 Wellington Street

London

SE18 6NY

REGISTERED NUMBER:

12691969 (England and Wales)

ACCOUNTANTS:

Richmond Gatehouse LLP

Thames House, 2nd floor

3 Wellington Street

London

SE18 6NY

FIXED ASSETS

Intangible assets

4

1,431,250

1,518,750

Tangible assets

5

87,555

156,875

1,518,805

1,675,625

CURRENT ASSETS

Stocks

100,300

164,600

Debtors

6

176,663

196,459

Cash at bank and in hand

30,480

30,565

307,443

391,624

CREDITORS

Amounts falling due within one year

7

(1,128,429

)

(1,037,281

)

NET CURRENT LIABILITIES

(820,986

)

(645,657

)

TOTAL ASSETS LESS CURRENT LIABILITIES

697,819

1,029,968

CREDITORS

Amounts falling due after more than one year

8

(1,400,179

)

(1,507,358

)

NET LIABILITIES

(702,360

)

(477,390

)

CAPITAL AND RESERVES

Called up share capital

9

100

100

Retained earnings

10

(702,460

)

(477,490

)

SHAREHOLDERS' FUNDS

(702,360

)

(477,390

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 December 2025 and were signed on its behalf by:

B Tuffour - Director

T O Amesimeku - Director

1.	STATUTORY INFORMATION

B & T Prescriptions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2024 - 14 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

1,750,000

AMORTISATION

At 1 April 2024

231,250

Amortisation for year

87,500

At 31 March 2025

318,750

NET BOOK VALUE

At 31 March 2025

1,431,250

At 31 March 2024

1,518,750

5.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Motor

machinery

fittings

vehicles

Totals

£

£

£

£

COST

At 1 April 2024

and 31 March 2025

88,527

168,479

20,270

277,276

DEPRECIATION

At 1 April 2024

54,947

53,208

12,246

120,401

Charge for year

22,132

42,120

5,068

69,320

At 31 March 2025

77,079

95,328

17,314

189,721

NET BOOK VALUE

At 31 March 2025

11,448

73,151

2,956

87,555

At 31 March 2024

33,580

115,271

8,024

156,875

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

127,680

139,017

Other debtors

48,983

57,442

176,663

196,459

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

1,344

-

Trade creditors

322,678

353,613

Taxation and social security

-

28,752

Other creditors

804,407

654,916

1,128,429

1,037,281

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

1,400,179

1,507,358

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

100

Ordinary

£1

100

100

10.

RESERVES

Retained

earnings

£

At 1 April 2024

(477,490

)

Deficit for the year

(224,970

)

At 31 March 2025

(702,460

)

11.	RELATED PARTY DISCLOSURES

The company is jointly controlled by the directors.